Calendario›BIAF›Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphyrin (TCPP) for Detection of Lung Cancer
Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphyrin (TCPP) for Detection of Lung Cancer
Ensayo de bioAffinity Technologies, Inc. en Cancer de pulmon.
Más ensayos de: Cáncer de pulmón.
- Fase
- no aplica
- Estado
- Completado
- Participantes
- 197
- Centros
- 5
- Fin del objetivo primario
- ago 2018
previstos
fecha real
Qué significa cada fase y cada estado.
Estudio observacional. Comenzó en sep 2016.
Qué mide
Optimizacion del ensayo (320 dias)
Cómo lo describe el promotor
En el documentoEn inglés, del registroThe primary objective of this study is optimization of the assay to discriminate between cancer cells and non-cancer cells in sputum samples by the performance of experiments that will determine methods to liquefy sputum, select proper fixatives and buffers, determine the efficacy of use of methyl-beta-cyclodextrin (MBCD) in sputum processing and determine the use of flow cytometry for high-throughput, and in the establishment of cell count and sputum cell populations in patient samples. The secondary objective of this study is comparison of the characteristics of sputum from three cohorts labeled with CyPath Lung to determine differential characteristics between samples taken from Participants who are not at high risk for lung cancer, Participants at high risk for lung cancer who are free of the disease and Participants with confirmed lung cancer.
Más ensayos de BIAF
| Ensayo | Fase | Estado | Lectura de resultados |
|---|---|---|---|
| Collection of Sputum and Labeling for Lung Cancer | no aplica | Reclutando pacientes | dic 2025 (prevista, ya pasada: sin actualizar en el registro) |
| BA-004 | Sin fase asignada | Reclutando pacientes | abr 2029 (prevista) |
| Detection of Abnormal Respiratory Cell Populations in Lung Cancer Screening Patients Using the CyPath Lung Assay | no aplica | Sin noticias del promotor | mar 2024 (prevista, ya pasada: sin actualizar en el registro) |
| CyPath® | Sin fase asignada | Completado | abr 2015 (real) |
Todos los de BIAF, en su ficha.
Ficha completa en ClinicalTrials.gov (NCT03837600), actualizada en jul 2023.